1. Home
  2. NTRA vs CHK Comparison

NTRA vs CHK Comparison

Compare NTRA & CHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • CHK
  • Stock Information
  • Founded
  • NTRA 2003
  • CHK 1989
  • Country
  • NTRA United States
  • CHK United States
  • Employees
  • NTRA N/A
  • CHK N/A
  • Industry
  • NTRA Medical Specialities
  • CHK Oil & Gas Production
  • Sector
  • NTRA Health Care
  • CHK Energy
  • Exchange
  • NTRA Nasdaq
  • CHK Nasdaq
  • Market Cap
  • NTRA 13.7B
  • CHK 11.6B
  • IPO Year
  • NTRA 2015
  • CHK 1993
  • Fundamental
  • Price
  • NTRA $129.95
  • CHK $72.99
  • Analyst Decision
  • NTRA Strong Buy
  • CHK Buy
  • Analyst Count
  • NTRA 15
  • CHK 12
  • Target Price
  • NTRA $123.64
  • CHK $102.90
  • AVG Volume (30 Days)
  • NTRA 1.2M
  • CHK 1.9M
  • Earning Date
  • NTRA 11-06-2024
  • CHK 10-29-2024
  • Dividend Yield
  • NTRA N/A
  • CHK 3.14%
  • EPS Growth
  • NTRA N/A
  • CHK N/A
  • EPS
  • NTRA N/A
  • CHK 3.21
  • Revenue
  • NTRA $1,360,503,000.00
  • CHK $4,097,000,000.00
  • Revenue This Year
  • NTRA $42.99
  • CHK N/A
  • Revenue Next Year
  • NTRA $13.11
  • CHK $153.67
  • P/E Ratio
  • NTRA N/A
  • CHK $22.78
  • Revenue Growth
  • NTRA 46.13
  • CHK N/A
  • 52 Week Low
  • NTRA $36.90
  • CHK $69.12
  • 52 Week High
  • NTRA $128.28
  • CHK $93.58
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 66.43
  • CHK 51.39
  • Support Level
  • NTRA $114.62
  • CHK $69.12
  • Resistance Level
  • NTRA $118.52
  • CHK $73.27
  • Average True Range (ATR)
  • NTRA 4.62
  • CHK 1.76
  • MACD
  • NTRA 0.87
  • CHK 0.39
  • Stochastic Oscillator
  • NTRA 99.77
  • CHK 80.47

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About CHK Chesapeake Energy Corporation

Chesapeake Energy Corp is a us-based exploration and production company. It is engaged in the acquisition, exploration, and development of properties for the production of oil, natural gas, and natural gas liquids from underground reservoirs. Geographically, the company focuses on areas of Marcellus, Northern Appalachian Basin in Pennsylvania; Haynesville, Northwestern Louisiana (Gulf Coast); and Eagle Ford, South Texas.

Share on Social Networks: